Anbieter: Anybook.com, Lincoln, Vereinigtes Königreich
EUR 49,50
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has hardback covers. In good all round condition. No dust jacket. Please note the Image in this listing is a stock photo and may not match the covers of the actual item,800grams, ISBN:9780080427928.
Anbieter: BooksRun, Philadelphia, PA, USA
Hardcover. Zustand: New. 1. The item is brand new, never used or read. It's in perfect condition and may include supplements and/or access codes or come shrink-wrapped.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 192,56
Anzahl: 3 verfügbar
In den WarenkorbZustand: New. pp. 694.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 235,03
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 236,82
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: preigu, Osnabrück, Deutschland
Taschenbuch. Zustand: Neu. Specification of Drug Substances and Products | Development and Validation of Analytical Methods | Christopher M. Riley (u. a.) | Taschenbuch | Einband - flex.(Paperback) | Englisch | 2020 | Elsevier | EAN 9780081028247 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 291,22
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Sprache: Englisch
Verlag: Elsevier - Health Sciences Division Sep 2024, 2024
ISBN 10: 0443134669 ISBN 13: 9780443134661
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware - Specification of Drug Substances and Products: Development and Validation of Analytical Methods, Third Edition contains chapters discussing the unique requirements for the universal critical quality attributes, as well as the specific tests required to characterize and control different types of products, ranging in complexity from small molecules in immediate release oral dosage forms to complex products such as drug-antibody conjugates and mRNA-based products. This substantially expanded revision of the second edition will serve as practical comprehensive reference for scientists, managers, educators, and consultants involved in the development and regulation of pharmaceutical products.